Koers Medicure Inc Toronto S.E.
Aandelen
MPH
CA58469E4085
Biotechnologie & Medisch Onderzoek
Omzet 2022 | 23,06 mln. 16,86 mln. 15,78 mln. | Omzet 2023 | 21,69 mln. 15,86 mln. 14,84 mln. | Marktkapitalisatie | 14,61 mln. 10,68 mln. 10 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | 1 mln. 731K 684K | Nettowinst (verlies) 2023 | - 0 0 | EV/omzet 2022 | 0,28 x |
Nettoliquiditeiten 2022 | 4,01 mln. 2,93 mln. 2,74 mln. | Nettoliquiditeiten 2023 | 5,82 mln. 4,26 mln. 3,99 mln. | EV/omzet 2023 | 0,4 x |
K/w-verhouding 2022 |
7,71
x | K/w-verhouding 2023 |
-15,6
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 72,89% |
Recentste transcriptie over Medicure Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Albert Friesen
CEO | Chief Executive Officer | 76 | 15-09-97 |
Haaris Uddin
DFI | Director of Finance/CFO | - | 01-06-22 |
Neil Owens
PSD | President | - | 01-01-14 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Arnold Naimark
BRD | Director/Board Member | 90 | 28-02-00 |
Peter Quick
BRD | Director/Board Member | 68 | 29-11-05 |
Albert Friesen
CEO | Chief Executive Officer | 76 | 15-09-97 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-2,31% | 103 mld. | |
+0,56% | 95,28 mld. | |
+1,69% | 22,15 mld. | |
-17,37% | 21,02 mld. | |
-9,30% | 18,15 mld. | |
-41,01% | 16,74 mld. | |
-14,85% | 16,05 mld. | |
+3,21% | 13,68 mld. | |
+33,54% | 12,17 mld. |